diphenyl has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A; Anderson, MS; Chen, Y; Eveland, SS; Guo, Q; Hammond, ML; Hyland, SA; Latham, MJ; Lu, Z; Milot, DP; Napolitano, JB; Peterson, LB; Sinclair, PJ; Sparrow, CP; Tan, E; Theberge, A; Tong, X; Wright, SD; Xu, SS | 1 |
| Adam, LP; Bassolino-Klimas, D; Ewing, WR; Harrity, T; Huang, Y; Jacobson, BL; Kish, K; Lavoie, TB; Magnin, DR; Parker, R; Patel, M; Robl, JA; Sheriff, S; Simpkins, L; Stoffel, R; Stouch, TR; Sulsky, R; Taunk, P; Taylor, DS; Zhu, Y | 1 |
2 other study(ies) available for diphenyl and Disease Models, Animal
| Article | Year |
|---|---|
Design of a novel class of biphenyl CETP inhibitors.
Topics: Animals; Benzylamines; Biphenyl Compounds; Carbamates; Cholesterol Ester Transfer Proteins; Disease Models, Animal; Drug Design; Lipoproteins, HDL; Mice; Mice, Transgenic; Structure-Activity Relationship | 2010 |
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).
Topics: Adipocytes; Animals; Azoles; Binding Sites; Biphenyl Compounds; Disease Models, Animal; Epidermis; Fatty Acid-Binding Proteins; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Models, Chemical; Radioligand Assay | 2007 |